[Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
D000227:Adenine Nucleotides / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002396:Catechols / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D066298:In Vitro Techniques; D010879:Piperazines / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D015016:Yohimbine / Q000494:pharmacology*
D000227:Adenine Nucleotides; D000317:Adrenergic alpha-Antagonists; D002396:Catechols; D010879:Piperazines; D014665:Vasodilator Agents; D015016:Yohimbine; D012701:Serotonin; D000244:Adenosine Diphosphate; D003094:Collagen; C003154:pipratecol; D004837:Epinephrine
Effetto della raubasina e del pipratecol sull'aggregazione piastrinica e sulla reazione di liberazione.